AgNovos Bioscience Revenue
Medical Equipment Manufacturing • 
Derwood, Maryland, United States • 21-50 Employees
AgNovos Bioscience revenue & valuation
| Annual revenue | $14,000,000 |
| Revenue per employee | $318,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $44,700,000 |
| Total funding | No funding |
Key Contacts at AgNovos Bioscience
Lindsey Belcher
Director, Fp&A And Treasury
Sabine Burgard
Clinical Account Director
Carl Harrison
Sr. Director, Applications
Dan Plonski
Director Global Regulatory Affairs
Carrie Lorenz
Associate Director Product Development
Jeffrey Shimp
Director, It Infrastructure And Development
Aaron Price
Director Clinical Operations
Jeff Jeffrey N. Shimp
Director Of It
Company overview
| Headquarters | 7301 Calhoun Place Suite 100, Suite 100, Rockville, MD 20855, US |
| Phone number | +16093192664 |
| Website | |
| SIC | 809 |
| Keywords | Healthcare, Women'S Health, Osteoporosis, Medical Technology, Bone Health, Fragility Fracture |
| Founded | 2012 |
| Employees | 21-50 |
| Socials |
AgNovos Bioscience Email Formats
AgNovos Bioscience uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@agnovos.com), used 76.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@agnovos.com | 76.3% |
{first name}{last name} | johndoe@agnovos.com | 18.4% |
{first initial}{second initial} | jo@agnovos.com | 2.6% |
{first initial} | j@agnovos.com | 2.6% |
About AgNovos Bioscience
AgNovos Biocience is a developer of new therapies that leverage proprietary, bone-building technology and regenerative medicine to address unmet needs in the treatment of bone disease. The Company’s first product, the OSSURE Local Osteo-Enhancement Procedure (LOEP) kit has been evaluated in multiple clinical studies and is available in select markets. The Company has initiated RESTORE, a randomized, controlled, prospective, single-blinded, multi-national study designed to evaluate the impact of OSSURE LOEP on the risk of secondary hip fractures. RESTORE is one of the largest prospective studies ever conducted in orthopedic traumatology. The data generated will be critical to gaining access to new markets, including the U.S. and Japan. The Company has also developed the AGN1 LOEP SV kit investigational device intended to treat stable but painful vertebral compression fractures. That device has received both a Breakthrough Device designation and an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration. AgNovos Bioscience is privately held and has its corporate headquarters in New York City with manufacturing, research & development, and corporate support services located in Rockville, MD.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
AgNovos Bioscience has 28 employees across 10 departments.
Departments
Number of employees
Funding Data
AgNovos Bioscience has never raised funding before.
AgNovos Bioscience Tech Stack
Discover the technologies and tools that power AgNovos Bioscience's digital infrastructure, from frameworks to analytics platforms.
Hosting
Security
Analytics
JavaScript frameworks
UI frameworks
Miscellaneous
Miscellaneous
CDN
JavaScript frameworks
Miscellaneous
Font scripts
Italy
Netherlands
United Kingdom
Frequently asked questions
4.8
40,000 users
